CNTA
CentessaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CNTA vs peer average
72/100
CNTA vs. peer average (B vs. C)
Grade spread
A 1 · B 1 · C 3 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CORT is the first available peer comparator.
Corcept offers another mid-cap biotech reference for how specialized clinical assets can trade around catalysts, but it is not a direct read-through because CNTA's near-term valuation is dominated by the Lilly takeout structure.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CNTA
Centessa
CORT
Corcept Therapeutics
Grade
B
B
Momentum
84
94
Value
41
59
Sentiment
43
15
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CORT
CNTA / CORT
Grade Position
Above peers
CNTA vs. peer average (B vs. C)
72/100
Momentum
84
CORTValue
41
CORTSentiment
43
CNTARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CNTA
CORT is the first peer returned for this comparison set.